These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15631651)

  • 21. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
    Yu C; Krystal G; Dent P; Grant S
    Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of SK-7041, one of novel histone deacetylase inhibitors, and STI571-induced synergistic apoptosis in chronic myeloid leukemia.
    Kim BS; Bae E; Kim YJ; Ahn KS; Park J; Rhee JY; Lee YY; Kim Y; Lee D; Kim BK; Yoon SS
    Anticancer Drugs; 2007 Jul; 18(6):641-7. PubMed ID: 17762392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.
    Czechowska A; Poplawski T; Drzewoski J; Blasiak J
    Chem Biol Interact; 2005 Apr; 152(2-3):139-50. PubMed ID: 15840387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line.
    Kotaki M; Motoji T; Takanashi M; Wang YH; Mizoguchi H
    Cancer Lett; 2003 Sep; 199(1):61-8. PubMed ID: 12963124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Signal pathway in apoptosis of K562 cells induced by STI571].
    Wang SY; Sun CH; Wei M; Ma WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1010-5. PubMed ID: 18928585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cells.
    Majsterek I; Arabski M; Czechowska A; Pytel D; Morawiec Z; Morawiec-Bajda A; Blasiak J
    Z Naturforsch C J Biosci; 2006; 61(11-12):896-902. PubMed ID: 17294703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of STI571 combined with As₂O₃ on proliferation, apoptosis and caspase 3, Bcl-xL expression of K562 cells].
    Chen NY; Wang J; Wang XM; Zhang HX; Yan ZY; Wang YM; Zhang S; Yan B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):882-6. PubMed ID: 20723293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential tyrosine phosphorylation of leukemic cells during apoptosis as a result of treatment with imatinib mesylate.
    Park J; Kim S; Oh C; Yoon SS; Lee D; Kim Y
    Biochem Biophys Res Commun; 2005 Oct; 336(3):942-51. PubMed ID: 16157305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells.
    Boren J; Cascante M; Marin S; Comín-Anduix B; Centelles JJ; Lim S; Bassilian S; Ahmed S; Lee WN; Boros LG
    J Biol Chem; 2001 Oct; 276(41):37747-53. PubMed ID: 11489902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition by STI571 in combination with radiation in human chronic myelogenous leukemia K562 cells.
    Huguet F; Giocanti N; Hennequin C; Croisy M; Touboul E; Favaudon V
    Mol Cancer Ther; 2008 Feb; 7(2):398-406. PubMed ID: 18281522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells].
    Li JE; Sun GL; Wu YL; Wu WL
    Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):580-3. PubMed ID: 14720443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.
    Kindler T; Breitenbuecher F; Kasper S; Stevens T; Carius B; Gschaidmeier H; Huber C; Fischer T
    Leukemia; 2003 Jun; 17(6):999-1009. PubMed ID: 12764361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line.
    Rabizadeh E; Merkin V; Belyaeva I; Shaklai M; Zimra Y
    Leuk Res; 2007 Aug; 31(8):1115-23. PubMed ID: 17267032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
    Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM
    Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Establishment of K562 cell lines resistant to STI571 and a preliminary biological study].
    Gao L; Wang JM; Xu XP; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):584-9. PubMed ID: 15498115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
    Jakubowska J; Wasowska-Lukawska M; Czyz M
    Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation.
    Chandramohan Reddy T; Bharat Reddy D; Aparna A; Arunasree KM; Gupta G; Achari C; Reddy GV; Lakshmipathi V; Subramanyam A; Reddanna P
    Toxicol In Vitro; 2012 Apr; 26(3):396-405. PubMed ID: 22245431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells.
    Chen Y; Hu D
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):41-4. PubMed ID: 15165112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.